Full Text View
Tabular View
No Study Results Posted
Related Studies
Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
This study has been completed.
Study NCT00050713   Information provided by National Institutes of Health Clinical Center (CC)
First Received: December 17, 2002   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Membranous Glomerulonephritis
Additional conditions recognized in this trial
Glomerulonephritis
Glomerulonephritis, Membranous
More general conditions related to this trial
Autoimmune Diseases
Immune System Diseases
Kidney Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services